Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer
Kwon, M. Kim, S. T. Hong, J. Y. Kim, G. Smith, S. Mortimer, P. G. LoembE, B. Kang, W. K. Lee, J.
Kwon, M.
Kim, S. T.
Hong, J. Y.
Kim, G.
Smith, S.
Mortimer, P. G.
LoembE, B.
Kang, W. K.
Lee, J.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Kwon M, Kim ST, Hong JY, Kim G, Smith S, Mortimer PG, et al. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301211.